Multi-drug resistant nephrotic syndrome (Q92377): Difference between revisions

← Older edit

@@ Property / Verification Status @@
+Concluído
@@ Property / Verification Status: Concluído / rank @@
+Normal rank
@@ Property / Knowledge Architect @@
+https://pauloleads.com.br/cases-publicos/
+Normal rank
@@ Property / Collection date @@
+August 2026Timestamp +2026-08-15T00:00:00Z
Timezone +00:00
Calendar Gregorian
Precision 1 day
Before 0
After 0
-Timestamp
++2026-08-15T00:00:00Z
-Timezone
++00:00
-Calendar
+Gregorian
-Precision
+day
 Before
 After
@@ Property / Collection date: 15 August 2026 / rank @@
+Normal rank

Latest revision as of 07:31, 16 August 2026

This diagnosis refers to steroid resistant nephrotic syndrome where other immunosuppressive agents such as calcineurin inhibitors (cyclosporine, tacrolimus), mycophenolate and other immunosuppressive agents have been be trialled but have not resulted in remission. This entity can be due to many genetic, histological or other conditions. Reference: Nephrology WG Kidney Disease: Improving Global Outcomes (KDIGO) Glomerulonephritis Work Group. KDIGO Clinical Practice Guideline for Glomerulonephritis. Kidney inter., Suppl. 2012; 2: 139-274.

Language	Label	Description	Also known as
default for all languages	ID_22053390
English	Multi-drug resistant nephrotic syndrome	This diagnosis refers to steroid resistant nephrotic syndrome where other immunosuppressive agents such as calcineurin inhibitors (cyclosporine, tacrolimus), mycophenolate and other immunosuppressive agents have been be trialled but have not resulted in remission. This entity can be due to many genetic, histological or other conditions. Reference: Nephrology WG Kidney Disease: Improving Global Outcomes (KDIGO) Glomerulonephritis Work Group. KDIGO Clinical Practice Guideline for Glomerulonephritis. Kidney inter., Suppl. 2012; 2: 139-274.